tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Marc Goodman, 184 are a BUY (76.67%), 49 are a HOLD (20.42%), 7 are a SELL (2.92%).
Analyst Marc Goodman, currently employed at LEERINK, carries an average stock price target met ratio of 60.28% that have a potential upside of 33.97% achieved within 336 days.
Marc Goodman’s has documented 431 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 07-May-2025.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $270 was fulfilled within 3 days with a profit of $41.55 (18.19%) receiving and performance score of 60.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$251
$17.09 (7.31%)
$205
5 days ago
(02-Oct-2025)
15/16 (93.75%)
$17.09 (7.31%)
300
Buy
$270
$36.09 (15.43%)
$195
21 days ago
(16-Sep-2025)
2/3 (66.67%)
$49.19 (22.28%)
121
Buy
$235
$1.09 (0.47%)
$200
22 days ago
(15-Sep-2025)
14/14 (100%)
$18.74 (8.67%)
483
Buy
$245
$11.09 (4.74%)
$210
23 days ago
(14-Sep-2025)
16/17 (94.12%)
$27.39 (12.59%)
244
Buy
$260
$26.09 (11.15%)
$240
26 days ago
(11-Sep-2025)
8/9 (88.89%)
$41.66 (19.08%)
463
Which stock is Marc Goodman is most bullish on?
What Year was the first public recommendation made by Marc Goodman?
